Thomson Reuters/Uni...
Health Care: Drugs
Perrigo Company (PRGO: NASDAQ)
$119.48 -0.33 | -0.28%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 401.61M | 339.20M | 222.55M | 144.05M |
| Operating Gains/Losses | -12.14M | 2.15M | -750.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -49.35M | -107.24M | -6.89M | 6.45M |
| (Increase) Decrease in Inventories | 5.35M | -30.42M | -30.20M | 341.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -23.56M | 57.80M | -21.17M | 24.82M |
| (Decrease) Increase In Other Current Liabilities | 21.37M | 55.94M | 47.85M | -21.17M |
| (Increase) Decrease In Other Working Capital | -5.67M | 12.91M | 4.94M | -1.07M |
| Other Non-Cash Items | 12.95M | -1.43M | 32.06M | 36.20M |
| Net Cash From Continuing Operations | 513.38M | 373.96M | 314.17M | 258.34M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 513.38M | 373.96M | 314.17M | 258.34M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -120.19M | -99.44M | -55.89M | -59.24M |
| Acquisitions | -573.69M | -934.00K | -832.82M | -88.25M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 9.75M | -10.75M | -29.26M | 1.12M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -684.13M | -110.57M | -917.98M | -146.37M |
| Issuance of Debt | 1.09B | 150.00M | 625.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 11.62M | 14.34M | 31.30M | 12.35M |
| Repayment of Long-Term Debt | -612.68M | -201.23M | -173.77M | -45.12M |
| Repurchase of Capital Stock | -8.24M | -8.31M | -71.09M | -62.49M |
| Payment of Cash Dividends | -29.02M | -25.30M | -22.33M | -19.96M |
| Other Financing Charges, Net | 7.80M | 11.71M | -5.81M | 0.00 |
| Net Cash From Financing Activities | 458.72M | -58.79M | 383.30M | -115.21M |
| Effect of Exchange Rate Changes | 4.43M | -4.26M | 1.93M | 769.00K |
| Net Change in Cash & Cash Equivalents | 292.38M | 200.34M | -218.57M | -2.47M |
Portfolios with PRGO
- Portfolio NameUser Type
- ProRuane Cunniff
- ProNavellier & Associates
- ContributorTechnical Setups for the We...
- UserPardini´s Portfolio
- ContributorMost-Searched Stocks for th...
- ContributorRocket Stocks for the Week ...
- Contributor8 Pharma Stocks to Watch
- Contributor8 Health Care Stocks Inside...
- ProEdward Owens
- ContributorCramer's Stocks Worth Holdi...
Latest PRGO Headlines from TheStreet
- Perrigo Stock Hits New 52-Week High (PRGO) 04.02.13 | 12:04 pm
- Perrigo Company (PRGO): Today's Featured Health Care Laggard 03.07.13 | 05:03 pm
- Perrigo Stock To Go Ex-dividend Tomorrow (PRGO) 02.26.13 | 09:02 am
- Cramer's 6 Stocks in 60 Seconds: SBAC BLK IP SAP ZNGA PRGO (Update 1) 02.25.13 | 05:02 pm
- Perrigo Company (PRGO): Today's Featured Drugs Winner 02.25.13 | 05:02 pm
- 4 Stocks Pushing The Drugs Industry Higher 02.25.13 | 12:02 pm
- Perrigo Company (PRGO): Today's Featured Drugs Winner 02.11.13 | 05:02 pm
- Perrigo Rises On Unusually High Volume (PRGO) 02.01.13 | 12:02 pm
- Perrigo Company (PRGO): Today's Featured Health Care Winner 01.31.13 | 05:01 pm
- Perrigo Company (PRGO): Today's Featured Health Care Laggard 01.24.13 | 05:01 pm
Press Releases for PRGO
- Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications - PR Newswire 05.13.13 | 10:05 am
- Perrigo Company Announces Quarterly Dividend - PR Newswire 05.02.13 | 08:05 am
- Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013 - PR Newswire 04.23.13 | 02:04 pm
- Perrigo Acquisition Of Velcera, Inc. -- Known For Its PetArmor® Franchise Of Flea And Tick Treatments -- Closes Today - PR Newswire 04.01.13 | 10:04 am
- Perrigo Company Closes Acquisition Of Companion Animal Health Company, Velcera, Inc. - PR Newswire 04.01.13 | 09:04 am
- The Pomerantz Firm, Glancy Binkow & Goldberg LLP, And Robbins Geller Rudman & Dowd LLP Announce The Notice Of Proposed Settlement Of The In Re: Perrigo Company Securities Litigation - PR Newswire 03.22.13 | 09:03 am
- Perrigo To Begin Shipments Of Guaifenesin Extended-Release 600mg Tablets, The First Store Brand Equivalents To Mucinex® 600mg Extended Release Tablets - PR Newswire 03.18.13 | 09:03 am
- Perrigo Company To Present At The Barclays Global Healthcare Conference - PR Newswire 03.11.13 | 11:03 am
- Perrigo Company To Present At The RBC Global Healthcare Conference - PR Newswire 02.25.13 | 02:02 pm
- Perrigo Confirms First To File Patent Challenge For Generic Version Of Testosterone Gel 1.62% - PR Newswire 02.19.13 | 09:02 am
Partner Headlines for PRGO
- Stocks Mixed Near Midday; Dillard's, 3D Systems Down - Investor's Business Daily 02.25.13 | 12:02 pm
- Perrigo expands UK presence - Financial Times 02.11.13 | 05:02 pm
- 106 Dividend Champions For December - Seeking Alpha 12.01.12 | 06:12 am
- Stocks Slide On Fiscal Cliff Worries; Retailers Hit - Investor's Business Daily 11.08.12 | 05:11 pm
- Stocks Plunge As Volume Surges - Investor's Business Daily 11.07.12 | 04:11 pm
- Stocks Stay In Deep Red; Whole Foods Reports After Close - Investor's Business Daily 11.07.12 | 02:11 pm
- Stocks Dive In Post-Election Riptide; Hospitals Rise - Investor's Business Daily 11.07.12 | 10:11 am
- Encouraging News for Perrigo - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- Perrigo Seeks Generic Approval - Analyst Blog - NASDAQ 09.10.12 | 02:09 pm
- Perrigo Seeks Generic Approval - Analyst Blog - Zacks 09.10.12 | 10:09 am
